Description
TYPBAR is a highly purified Vi polysaccharide vaccine. It contains the cell surface VI Polysaccharide extracted from the Salmonella typhi Ty2 strain. The vaccine appears as a clear, colourless solution.
TYPBAR
- Typbar (typhoid vaccine) is the powerful tool
- 21 million people are affected by Typhoid with almost 161,000 globally.
- XDR-TF is resistant to both first line and second line drugs as well as third generation cephalosporin.
- XDR-TF is now growing more insusceptible to the use of Azithromycin.
Related products
Copyright ©2023 all rights reserved
Designed by HSC IT department